Medical Marijuana 411 Interviews Dr. David Bearman of the AACM


 

Medical Marijuana 411 Interviews Dr. David Bearman of the AACM – MedicalMarijuana411.com sits down with David Bearman, MD Dr. Bearman helped found the countrys third free clinic in Seattle, Washington in 1967, directed the Haight Ashbury Drug Treatment Program, and founded the Isla Vista Medical Clinic in 1970. He has worked at all levels of government, including being a Medical Officer in the US Public Health Service, Director of Health Services at San Diego State University and Director and Medical Officer of the Sutter County Health Department. In 2001 after retiring as Deputy Director of the Santa Barbara Regional Health Authority (the oldest Medicaid-managed care plan in the country), Dr. Bearman began his private practice of pain management. He has also given expert-witness testimonies in over 350 court cases. Dr. Bearman has authored numerous articles and the book Demons, Discrimination and Dollars: A Brief History of American Drug Policy. He wrote the medicinal cannabis section in ABC-CLIOs online publication, Emerging Issues in the 21st Century World-System. He has been published in the Harvard Business Review and the Journal of Social Issues. The Journal of Medical Economics selected him as one of their “Handpicked Panel of 110 Top Medical Thinkers,” and The Wall Street Journal named him Doctor of the Day in 2007.

 

High or dry? Staying sober for New Year's Eve

Filed under: drug treatment programs in san diego

The holidays often mean an excess of booze and drugs. Occasional drinkers fail to moderate and addiction programs around the country note upticks in patient loads soon after the new year, high season for relapsers and those seeking treatment for the …
Read more on U-T San Diego

 

Biotech Black Belt

Filed under: drug treatment programs in san diego

First, a little background. San Diego-based Santarus was founded in 2004 to launch a heartburn medication called Zegerid. This is basically a … They have proven they can spot a promising niche drug, protect the patent and increase sales (most of …
Read more on Investing Daily